Personal Genome Diagnostics is the first company to obtain a license to materials from a unique community registry and biorepository managed by Duke CTSI. The license marks a milestone for the MURDOCK Study, a longitudinal population health research program that enrolled its first participant in 2009. The registry and biorepository include samples and associated data from over 12,000 participants, based at CTSI’s Duke Kannapolis research site, now a part of the new Center for Precision Heal...
